Myocardial salvage after ST-segment-elevation myocardial infarction: comparison between prasugrel and clopidogrel in the presence or absence of high-residual platelet reactivity-Reference-Cited by-同舟云学术

Myocardial salvage after ST-segment-elevation myocardial infarction: comparison between prasugrel and clopidogrel in the presence or absence of high-residual platelet reactivity

Published:2019-08-19 Issue:4 Volume:28 Page:1422-1434
ISSN:1071-3581
Container-title:Journal of Nuclear Cardiology
language:en
Short-container-title:J. Nucl. Cardiol.

Author:

Yoshida Ruka,Takagi Kensuke,Ishii Hideki,Morishima Itsuro,Tanaka Akihito,Morita Yasuhiro,Kanzaki Yasunori,Nagai Hiroaki,Watanabe Naoki,Furui Koichi,Shibata Naoki,Yoshioka Naoki,Yamauchi Ryota,Komeyama Shotaro,Sugiyama Hiroki,Tsuboi Hideyuki,Murohara Toyoaki

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s12350-019-01852-3.pdf

Reference39 articles.

1. Gurbel PA, Bliden KP, Hiatt BL, O’Connor CM. Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-13.

2. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15.

3. Bonaca MP, Wiviott SD, Braunwald E, Murphy SA, Ruff CT, Antman EM, et al. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: Observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38). Circulation 2012;125:577-83.

4. Baber U, Sartori S, Aquino M, Kini A, Kapadia S, Weiss S, et al. Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study. Am Heart J 2017;188:73-81.

5. Danchin N, Lettino M, Zeymer U, Widimsky P, Bardaji A, Barrabes JA, et al. Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries. Eur Heart J Cardiovasc Pharmacother 2016;2:152-67.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimized gated a SPECT-derived myocardial salvage index: its prognostic significance in predicting major adverse cardiac events following acute myocardial infarction percussion;Annals of Nuclear Medicine;2024-01-04

2. Nanoparticle-Based Activatable MRI Probes for Disease Imaging and Monitoring;Chemical & Biomedical Imaging;2023-03-29

3. Effects of Clopidogrel Rehabilitation on Cardiac Protein Kinase C, Cardiac Heat Shock Protein 70, and CI in MIRI Rat Model;BioMed Research International;2022-10-13

4. Radionuclide imaging of jeopardized myocardium: From the beginning of the race to the finish line;Journal of Nuclear Cardiology;2019-09-23